Gene · 1585
Papers3,065
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,065
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Significance of High Expression of Circulating miR-222-3p in Patients With Unilateral Primary Aldosteronism. | J Clin Endocrinol Metab | 2026 | 40679395 | PubTator, text mining | PubMed |
| Emerging Therapies for Treatment-Resistant Hypertension: A Review of Lorundrostat and Related Selective Aldosterone Synthase Inhibitors. | Cardiol Rev | 2026 | 38358268 | PubTator, text mining | PubMed |
Erratum to the article: Aldosterone synthase deficiency due to homozygous CYP11B2 pathogenic variant with coexisting celiac disease: A case study and literature review. Pediatr Endocrinol Diabetes Metab 2025; 31 (3): 133-140. DOI: https://doi.org/10.5114/pedm.2025.155104. | Pediatr Endocrinol Diabetes Metab | 2025 | 41693196 | PubTator, text mining | PubMed |
| Disruptive effects of phthalates and their substitutes on adrenal steroidogenesis. | Front Endocrinol (Lausanne) | 2025 | 41613959 | PubTator, text mining | PubMed |
A Narrative Review of the Genetic Architecture of Systemic Hypertension: From Candidate Genes to Biobank-Scale Genome-Wide Association Studies and Sequencing, With Translational Pathways to Precision Care. | Cureus | 2025 | 41573461 | PubTator, text mining | PubMed |
| Endocrine disrupting chemicals and the adrenal gland. | Turk J Med Sci | 2025 | 41488240 | PubTator, text mining | PubMed |
| Association between CYP11B2 rs1799998 genetic variant with essential hypertension and antihypertensive response. | Per Med | 2025 | 41451765 | PubTator, text mining | PubMed |
| Genetic Scale for Predicting the No-Reflow Phenomenon in Myocardial Infarction. | Sovrem Tekhnologii Med | 2025 | 41426969 | PubTator, text mining | PubMed |
| Aldosterone Synthase Deficiency Type I in a Neonate: Diagnostic, Genetic, and Therapeutic Insights From a Novel CYP11B2 Variant. | Cureus | 2025 | 41426917 | PubTator, text mining | PubMed |
| Diabetes Mellitus and Chronic Kidney Disease: The Future Is Being Surpassed. | J Clin Med | 2025 | 41375628 | PubTator, text mining | PubMed |
| Adrenal Cortical Steroidogenic Enzyme Expression is Associated with Hypertension, Obesity and Corticosteroid Use: A Tissue Microarray Study of Human Adrenal Tissue. | Horm Metab Res | 2025 | 41360104 | PubTator, text mining | PubMed |
| Urine Extracellular Vesicle miRNA Changes Induced by Vicadrostat with/Without Empagliflozin in Patients with Chronic Kidney Disease. | Int J Mol Sci | 2025 | 41303298 | PubTator, text mining | PubMed |
| Aldosterone synthase deficiency due to homozygous CYP11B2 pathogenic variant with coexisting celiac disease: A case study and literature review. | Pediatr Endocrinol Diabetes Metab | 2025 | 41229259 | PubTator, text mining | PubMed |
| Complete Unilateral Adrenalectomy is Recommended to Prevent Residual Disease in Unilateral Primary Aldosteronism. | JCEM Case Rep | 2025 | 41221016 | PubTator, text mining | PubMed |
| A comprehensive narrative review on precision medicine approach to hypertension: exploring the role of genetics, epigenetics, microbiome, and artificial intelligence. | J Health Popul Nutr | 2025 | 41219783 | PubTator, text mining | PubMed |
| Female sex hormones do not drive the sex-specific mechanisms of obesity-related hypertension. | Am J Physiol Heart Circ Physiol | 2025 | 41187991 | PubTator, text mining | PubMed |
| Baxdrostat: A Next-Generation Aldosterone Synthase Inhibitor Offering New Hope in Resistant Hypertension. | Biomolecules | 2025 | 41154669 | PubTator, text mining | PubMed |
| Pheochromocytoma, cortisol-producing adenoma and bilateral primary aldosteronism in a single patient. | BMJ Case Rep | 2025 | 41151823 | PubTator, text mining | PubMed |
Inhibition of NPC Intracellular Cholesterol Transporter 1 Dually Regulates Aldosterone Secretion Via the Steroidogenic Acute Regulatory-Related Lipid Transfer Domain-3-Voltage-Dependent Anion Channel 1 Axis and Inositol 1,4,5-Trisphosphate Receptor Type 3-Calcium Signaling. | J Am Heart Assoc | 2025 | 41147391 | PubTator, text mining | PubMed |
| Efficacy and Safety of Lorundrostat in Uncontrolled and/or Treatment Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | High Blood Press Cardiovasc Prev | 2025 | 41107674 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1585/papers?page=8